Jill Wu
Stock Analyst at CMB International Securities
(4.77)
# 571
Out of 4,334 analysts
181
Total ratings
49.7%
Success rate
27.1%
Average return
Main Sectors:
Stocks Rated by Jill Wu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines AG | Maintained: Buy | $392 | $310.25 | +26.49% | 18 | May 7, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $670 → $620 | $448.28 | +38.31% | 7 | Apr 27, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Maintained: Buy | $12 → $18 | $12.01 | +52.46% | 4 | Apr 24, 2026 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Maintained: Buy | $45 → $46 | $33.72 | +37.63% | 7 | Apr 2, 2026 | |
| HKG: 1530 3SBio Inc. | Maintained: Buy | $37 → $35 | $19.23 | +81.33% | 9 | Apr 1, 2026 | |
| HKG: 6699 Angelalign Technology Inc. | Maintained: Buy | $86 → $92 | $72.20 | +27.27% | 4 | Mar 31, 2026 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Maintained: Buy | $9.4 → $8.7 | $5.22 | +66.67% | 4 | Mar 30, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $111 → $114 | $80.95 | +40.65% | 13 | Mar 30, 2026 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $182 → $186 | $116.60 | +59.35% | 10 | Mar 30, 2026 | |
| HKG: 2506 Xunfei Healthcare Technology Co., Ltd. | Maintained: Buy | $144 → $93 | $81.55 | +13.49% | 4 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $367 → $383 | $222.80 | +72.11% | 3 | Mar 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $7.69 | +69.70% | 14 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $39 | $32.72 | +19.19% | 10 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $499 → $507 | $474.20 | +6.94% | 9 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 → $82 | $57.30 | +43.11% | 3 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $98 → $100 | $70.75 | +41.03% | 7 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $39 | $27.44 | +41.03% | 10 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $5.32 | +94.36% | 1 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $25.90 | +36.91% | 1 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $64.15 | +25.13% | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $31 | $19.17 | +63.75% | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.57 | $7.95 | n/a | 2 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $34 | $34.04 | n/a | 3 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $52 | $7.91 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $21 | $84.80 | n/a | 5 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.43 → $3.33 | $2.26 | n/a | 3 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8.57 | $19.86 | n/a | 6 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.2 → $5.27 | $5.99 | n/a | 4 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.65 | $0.92 | n/a | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $0.71 | n/a | 2 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $49.86 | n/a | 1 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $24 | $9.19 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $58 | $3.86 | n/a | 1 | Aug 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.15 | $10.42 | n/a | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.77 | n/a | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $33 | $4.16 | n/a | 1 | Jul 24, 2023 |
BeOne Medicines AG
May 7, 2026
Maintained: Buy
Price Target: $392
Current: $310.25
Upside: +26.49%
Thermo Fisher Scientific
Apr 27, 2026
Maintained: Buy
Price Target: $670 → $620
Current: $448.28
Upside: +38.31%
InnoCare Pharma Limited
Apr 24, 2026
Maintained: Buy
Price Target: $12 → $18
Current: $12.01
Upside: +52.46%
Hansoh Pharmaceutical Group Company Limited
Apr 2, 2026
Maintained: Buy
Price Target: $45 → $46
Current: $33.72
Upside: +37.63%
3SBio Inc.
Apr 1, 2026
Maintained: Buy
Price Target: $37 → $35
Current: $19.23
Upside: +81.33%
Angelalign Technology Inc.
Mar 31, 2026
Maintained: Buy
Price Target: $86 → $92
Current: $72.20
Upside: +27.27%
Sino Biopharmaceutical Limited
Mar 30, 2026
Maintained: Buy
Price Target: $9.4 → $8.7
Current: $5.22
Upside: +66.67%
Innovent Biologics, Inc.
Mar 30, 2026
Maintained: Buy
Price Target: $111 → $114
Current: $80.95
Upside: +40.65%
Akeso, Inc.
Mar 30, 2026
Maintained: Buy
Price Target: $182 → $186
Current: $116.60
Upside: +59.35%
Xunfei Healthcare Technology Co., Ltd.
Mar 30, 2026
Maintained: Buy
Price Target: $144 → $93
Current: $81.55
Upside: +13.49%
Mar 29, 2026
Maintained: Buy
Price Target: $367 → $383
Current: $222.80
Upside: +72.11%
Mar 26, 2026
Maintained: Buy
Price Target: $14 → $13
Current: $7.69
Upside: +69.70%
Mar 26, 2026
Maintained: Buy
Price Target: $36 → $39
Current: $32.72
Upside: +19.19%
Mar 25, 2026
Maintained: Buy
Price Target: $499 → $507
Current: $474.20
Upside: +6.94%
Mar 25, 2026
Maintained: Buy
Price Target: $88 → $82
Current: $57.30
Upside: +43.11%
Mar 24, 2026
Maintained: Buy
Price Target: $98 → $100
Current: $70.75
Upside: +41.03%
Mar 23, 2026
Maintained: Buy
Price Target: $54 → $39
Current: $27.44
Upside: +41.03%
Mar 12, 2026
Maintained: Buy
Price Target: $10
Current: $5.32
Upside: +94.36%
Feb 5, 2026
Maintained: Buy
Price Target: $35
Current: $25.90
Upside: +36.91%
Sep 3, 2025
Initiated Coverage: Buy
Price Target: $80
Current: $64.15
Upside: +25.13%
Aug 11, 2025
Maintained: Buy
Price Target: $34 → $31
Current: $19.17
Upside: +63.75%
Apr 3, 2025
Maintained: Buy
Price Target: $7.57
Current: $7.95
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $35 → $34
Current: $34.04
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $21 → $52
Current: $7.91
Upside: n/a
Oct 31, 2024
Maintained: Buy
Price Target: $20 → $21
Current: $84.80
Upside: n/a
Sep 2, 2024
Maintained: Buy
Price Target: $4.43 → $3.33
Current: $2.26
Upside: n/a
Sep 2, 2024
Maintained: Buy
Price Target: $10 → $8.57
Current: $19.86
Upside: n/a
Aug 30, 2024
Maintained: Buy
Price Target: $7.2 → $5.27
Current: $5.99
Upside: n/a
Jun 4, 2024
Maintained: Buy
Price Target: $1.65
Current: $0.92
Upside: n/a
Apr 9, 2024
Maintained: Buy
Price Target: $16 → $14
Current: $0.71
Upside: n/a
Aug 29, 2023
Maintained: Buy
Price Target: $22
Current: $49.86
Upside: n/a
Aug 28, 2023
Maintained: Buy
Price Target: $24 → $24
Current: $9.19
Upside: n/a
Aug 25, 2023
Initiated Coverage: Buy
Price Target: $58
Current: $3.86
Upside: n/a
Aug 23, 2023
Maintained: Buy
Price Target: $8.15
Current: $10.42
Upside: n/a
Aug 3, 2023
Rated: Hold
Price Target: n/a
Current: $1.77
Upside: n/a
Jul 24, 2023
Initiated Coverage: Buy
Price Target: $33
Current: $4.16
Upside: n/a